Cargando…
Dystrophin gene editing by CRISPR/Cas9 system in human skeletal muscle cell line (HSkMC)
OBJECTIVE(S): Duchene muscular dystrophy (DMD) is a progressive neuromuscular disease caused by mutations in the DMD gene, resulting in the absence of dystrophin expression leading to membrane fragility and myofibril necrosis in the muscle cells. Because of progressive weakness in the skeletal and c...
Autores principales: | Dara, Mahintaj, Razban, Vahid, Mazloomrezaei, Mohsen, Ranjbar, Maryam, Nourigorji, Marjan, Dianatpour, Mehdi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mashhad University of Medical Sciences
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591754/ https://www.ncbi.nlm.nih.gov/pubmed/34804433 http://dx.doi.org/10.22038/IJBMS.2021.54711.12269 |
Ejemplares similares
-
Using CRISPR/Cas9 System to Knock out Exon 48 in DMD Gene
por: Dara, Mahintaj, et al.
Publicado: (2021) -
CRISPR/Cas as a Potential Diagnosis Technique for COVID-19
por: Dara, Mahintaj, et al.
Publicado: (2020) -
Multiplex CRISPR/Cas9-Based Genome Editing for Correction of Dystrophin Mutations that Cause Duchenne Muscular Dystrophy
por: Ousterout, David G., et al.
Publicado: (2015) -
CRISPR/Cas9-Mediated Genome Editing Corrects Dystrophin Mutation in Skeletal Muscle Stem Cells in a Mouse Model of Muscle Dystrophy
por: Zhu, Pei, et al.
Publicado: (2017) -
Muscle-specific CRISPR/Cas9 dystrophin gene editing ameliorates pathophysiology in a mouse model for Duchenne muscular dystrophy
por: Bengtsson, Niclas E., et al.
Publicado: (2017)